Amman

Amman is distinguished by a sophisticated pharmaceutical manufacturing sector that exports over 4,500 products to 85 global markets.

The city is best known for its leadership in branded generics, with industry giants like Hikma Pharmaceuticals and Amman Pharmaceutical Industries driving regional innovation in ophthalmology and oncology.

Beyond traditional manufacturing, Amman is a rising center for biotechnology, leveraging the Jordan Food and Drug Administration's (JFDA) recent accession to the PIC/S to align with international Good Manufacturing Practices (GMP).

The ecosystem is anchored by world-class healthcare infrastructure, including the King Hussein Cancer Center, which serves as a regional beacon for advanced oncology research and specialized patient care.

Amman’s academic research environment is equally robust, supported by the University of Jordan and the Royal Scientific Society, which facilitate high-impact clinical trials and evidence-based healthcare projects.

In the realm of healthcare innovation, the city’s healthtech startups are pioneering digital health solutions, such as the national Hakeem electronic health records program.

The medical device sector is also expanding, with local firms increasingly focusing on R&D for specialized diagnostic tools and high-quality medical supplies.

This convergence of regulatory excellence, a skilled scientific workforce and a strategic location makes Amman a vital node for global life sciences investment and cross-border partnerships.

Consequently, the city continues to attract international stakeholders looking for a stable, high-growth environment for biotech R&D and pharmaceutical distribution.